Dr. Patrick T. Horn M.D. Ph.D. serves as
Chief Medical Officer of the Company. He previously served as Senior Vice President, Medical and Clinical Development at Orphan Technologies Ltd., a biopharmaceutical company, from January 2018 to July 2018. Prior to that, he served as
Chief Medical Officer at Tetraphase Pharmaceuticals, Inc., a biopharmaceutical company, from January 2011 to December 2017. Prior to that, he served as Vice President, Clinical & Medical Affairs at Dyax Corporation, a biopharmaceutical company, from September 2007 to December 2010. Previously, Dr. Horn served in various positions at Abbott Laboratories, a pharmaceutical company, from 2001 to 2006, most recently serving as Medical Director, Head of Clinical Pharmacology. Dr. Horn received a B.S. in Chemistry from the University of Illinois, a Ph.D. in the Pharmacological and Physiological Sciences from the University of Chicago and an M.D. from the University of Chicago, Pritzker School of Medicine.
How do I contact Patrick Taylor Horn?
Has Patrick Taylor Horn been buying or selling shares of Albireo Pharma?
Patrick Taylor Horn has not been actively trading shares of Albireo Pharma over the course of the past ninety days. Most recently, Patrick Taylor Horn sold 95 shares of the business's stock in a transaction on Friday, October 22nd. The shares were sold at an average price of $28.83, for a transaction totalling $2,738.85. Learn More on Patrick Taylor Horn's trading history.
Who are Albireo Pharma's active insiders?
